Seattle Genetics | SGEN - Рыночная капитализация



Рыночная капитализация Изменить Дата
AbbVie USD 364.22B 20.46B 2026-05
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Amgen USD 189.89B 13.64B 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Celldex Therapeutics USD 2.21B 99M 2026-05
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eisai JPY 1.25T 171.13B 2026-05
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 14.34B 3.44B 2026-05
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
Insmed USD 15.56B 19.73B 2026-05
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
Takeda JPY 8.33T 681.01B 2026-05
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05
Xencor USD 795M 98M 2026-05